Decoy Therapeutics is trading 7.93% down at $3.02 after falling from the August 20 close of $3.28, with no fresh company-specific catalyst identified.
- The latest identifiable company news was an August 3 intellectual-property update.
- The broader market is modestly higher pre-market, so the decline does not clearly track overall index direction.
- Recent weakness followed the August 12 quarterly loss announcement, but that catalyst is not new.